Nuvalent Inc vs Taskus Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Taskus Inc trades at $5.86 (market cap $532.07M). The key difference: Nuvalent Inc is far larger — about 18.4× Taskus Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals.
| NUVL | TASK | |
|---|---|---|
Market Cap | $9.81B | $532.07M |
Sector | Technology | Technology |
52-Week High | $123.96 | $18.21 |
52-Week Low | $72.16 | $4.57 |
Enterprise Value | $8.52B | $927.77M |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →